dc.contributor.author | Long, Aideen | |
dc.contributor.author | Ron, Dorit | |
dc.contributor.author | Adams, David R. | |
dc.contributor.author | Baillie, George S. | |
dc.contributor.author | O'Connor, Rosemary | |
dc.contributor.author | Kiely, Patrick A. | |
dc.date.accessioned | 2019-11-21T10:55:54Z | |
dc.date.available | 2019-11-21T10:55:54Z | |
dc.date.issued | 2013 | |
dc.date.submitted | 2013 | en |
dc.identifier.citation | Ron, D., Adams, D.R., Baillie, G.S., Long, A., O'Connor, R. & Kiely, P.A., RACK1 to the future--a historical perspective, 2013, Cell communication and signaling, CCS, 11, 53 | en |
dc.identifier.issn | 1478-811x | |
dc.identifier.other | Y | |
dc.description | PUBLISHED | en |
dc.description.abstract | This perspective summarises the first and long overdue RACK1 meeting held at the University of Limerick, Ireland,
May 2013, in which RACK1
’
s role in the immune system, the heart and the brain were discussed and its
contribution to disease states such as cancer, cardiac hypertrophy and addiction were described. RACK1 is a
scaffolding protein and a member of the WD repeat family of proteins. These proteins have a unique architectural
assembly that facilitates protein anchoring and the stabilisation of protein activity. A large body of evidence is
accumulating which is helping to define the versatile role of RACK1 in assembling and dismantling complex
signaling pathways from the cell membrane to the nucleus in health and disease. In this commentary, we first
provide a historical perspective on RACK1. We also address many of the pertinent and topical questions about this
protein such as its role in transcription, epigenetics and translation, its cytoskeletal contribution and the merits of
targeting RACK1 in disease. | en |
dc.description.sponsorship | This work was supported by grants received from; the Health Research Board
of Ireland (HRB) (Knowledge Exchange and Dissemination Scheme HRB/
KEDS/HRA/2009/188 and HRA/2009/188) (P.K.), the Irish Cancer Society (P.K.),
NIH/NIAAA P50 AA017072 (D.R), NIH-NIAAA R01 AA016848 (D.R) and funds
from the State of California for Medical Research on Alcohol and Substance
Abuse through the University of California, San Francisco (D.R), MRC grant
(MR/J007412/1) (G.B), the Health Research Board of Ireland (HRB) (A.L.), and
the Health Research Board (HRB) and Science Foundation Ireland (SFI) (R.
OC.). We are grateful to our colleagues in the Kiely and Ron Laboratories for
helpful discussions and critical review. | en |
dc.format.extent | 53 | en |
dc.language.iso | en | en |
dc.relation.ispartofseries | Cell communication and signaling : CCS; | |
dc.relation.ispartofseries | 11; | |
dc.relation.ispartofseries | 53; | |
dc.rights | Y | en |
dc.subject | RACK1 | en |
dc.subject | Protein kinase | en |
dc.subject.lcsh | RACK1 | en |
dc.title | RACK1 to the future – a historical perspective. | en |
dc.type | Journal Article | en |
dc.type.supercollection | scholarly_publications | en |
dc.type.supercollection | refereed_publications | en |
dc.identifier.peoplefinderurl | http://people.tcd.ie/longai | |
dc.identifier.rssinternalid | 183656 | |
dc.identifier.doi | http://dx.doi.org/10.1186/1478-811x-11-53 | |
dc.rights.ecaccessrights | openAccess | |
dc.identifier.orcid_id | 0000-0002-9918-9960 | |
dc.contributor.sponsor | science foundation ireland | en |
dc.identifier.uri | https://biosignaling.biomedcentral.com/articles/10.1186/1478-811X-11-53 | |
dc.identifier.uri | http://hdl.handle.net/2262/90816 | |